Pharma Pathway

SEPTEMBER 22, 2022

Limited-Walk-In Drive for Production -Formulation (OSD) On 23rd Sept’ 2022. Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Date: 23rd Sept’ 2022. Limited-Walk-In Drive for Production -Formulation (OSD) On 23rd Sept’ 2022. Granules India Pvt.

Pharmaceutical manufacturing 84

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 84

Pharma Pathway

SEPTEMBER 15, 2022

Limited-Walk-In Drive for Warehouse (OSD) On 16th Sept’ 2022. Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Walk-In Drive for Warehouse (OSD) On 16th Sept’ 2022 @ Granules India Limited (Gagillapur-Hyderabad). Date: 16th Sept’ 2022.

Pharmaceutical manufacturing 75

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 75

Pharma Pathway

SEPTEMBER 20, 2022

On 24th Sept’ 2022. SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards. On 24th Sept’ 2022 @ SMS Pharmaceuticals Ltd, Unit-II, Bachupally, Hyderabad.

Pharmaceutical 75

Pharmaceutical Pharmaceutical manufacturing Manufacturing Leads 75

Pharmaceutical Technology

DECEMBER 16, 2022

The pharmaceutical industry must improve its environmental footprint by investing in technology and expertise, as well as through better design of new drugs early in their development, according to a GlobalData survey of the pharmaceutical industry.

Manufacturing 64

Manufacturing Pharma Pharmaceutical manufacturing Pharmaceutical 64

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 108

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 108

Pharma Pathway

DECEMBER 8, 2022

Granules India Limited- Walk-In Drive for Granulation/ Compression/ Coating/ Capsule Filling/ QC/ Warehouse/ IPQA On 10th Dec’ 2022. Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Date: 10th Dec’ 2022. Job Description. Location: Hyderabad.

Pharmaceutical manufacturing 70

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 70

PM360

MAY 25, 2023

The pandemic had a huge impact on the way population health decision-makers (PHDMs) navigate our industry, and now that it’s clear many of these shifts are here to stay, pharmaceutical manufacturers need to adjust accordingly. We get so little comparative effectiveness data from pharma.”

Pharma 92

Pharma Manufacturing Pharmaceutical manufacturing Management 92

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. Let’s find out!

Pharma 52

Pharma Medicine Marketing Prospecting 52

European Pharmaceutical Review

OCTOBER 20, 2022

1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to be producing them in house. In particular, purified water and WFI are critical when producing sterile pharmaceutical drug products. Water quality from an Annex 1 and Pharma 4.0 Making the journey to PAT and Pharma 4.0.

Food and Drug Administration 86

Food and Drug Administration Pharma Manufacturing Food 86

Pharmaceutical Technology

MAY 23, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. The share represented by China was 0.03% lower than the 0.08% share it accounted for in Q4 2022.

Pharmaceutical 52

Pharmaceutical Government Pharmaceutical manufacturing Manufacturing 52

Pharma Marketing Network

JANUARY 18, 2023

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Marketing Networking 52

European Pharmaceutical Review

JUNE 6, 2023

BSI, a UK standards body, developed the new certification to the Antibiotic Manufacturing Standard published in June 2022. Join us today to hear from industry experts and Alliance members on their experience with this certification and what to expect going forward.

Manufacturing 91

Manufacturing Pharmaceutical manufacturing Pharmaceutical Pharma 91

Pharma Pathway

FEBRUARY 14, 2023

Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 52

Pharma Pathway

FEBRUARY 16, 2023

Granules India Limited- Walk-In Drive for Capsule Filling / Warehouse/ QC On 17th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Date: 17th Feb’ 2022 Time: 10:00 AM to 03:00 PM Venue: Granules India Limited, Sy.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 52

Pharma Pathway

MARCH 2, 2023

Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian.

Pharmaceutical manufacturing 81

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 81

Pharma Pathway

MARCH 14, 2023

Granules India Limited- Walk-In Interviews for Freshers in Warehouse/ Production On 17th Mar’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Passed out year: 2020 to 2022 Age: 18 -22 years Percentage: 60% & above in all Academics.

Pharmaceutical manufacturing 40

Pharmaceutical manufacturing Manufacturing Education Pharmaceutical 40

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

Marketing 69

Marketing Leads Pharmaceutical Manufacturing 69

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

Leads 52

Leads Pharmaceutical Marketing Manufacturing 52

pharmaphorum

DECEMBER 16, 2022

Achium outlined that, as of June 2022, over 72% of people in high-income countries had been vaccinated with at least one dose of a COVID-19 vaccine, while only 17% of people in low-income countries could say the same. The discussions over the treaty are set to continue for some time.

Distribution 79

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 79

PM360

DECEMBER 20, 2023

Additionally, it will delve into the current trends and challenges that pharma companies need to consider when devising successful market access strategies for this unique market. Despite the disruptive impact of the COVID-19 pandemic, steady growth has been evident in China’s pharmaceutical market and research environment. in the U.S.

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

JULY 21, 2023

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain.

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1]

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

AUGUST 9, 2022

Pharma Manufacturer Solutions. GM of Manufacturer Solutions. 1 GoodRx’s partnerships with pharma manufacturers and other key stakeholders in the healthcare industry enable them to offer discounts which have helped patients fill at least 80 million prescriptions that they otherwise could not afford.

Prescription 105

Prescription Medical Side effects Patients 105

European Pharmaceutical Review

DECEMBER 18, 2023

In 2023, the pharma industry has] witnessed tremendous advances in CAR T-cell immunotherapy of solid tumours” Another treatment modality that has witnessed significant advancement this year in the pharmaceutical industry, is cell and gene therapy. According to CPI, the facility is set to be completed in late 2025.

Manufacturing 95

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 95

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. In fact, the most recent estimate from the World Customs Organization places the global fake pharma market at $200 billion. But what exactly does this look like? .

Pharmaceutical 80

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 80

Pharmaceutical Technology

MARCH 22, 2023

Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Some large pharma companies have initiated indirect reshoring activities by increasing investment in new research and development and production units in their European facilities. “Due

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105

Pharmaceutical Technology

DECEMBER 19, 2022

in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Pierre Socha, partner at Amadeus Capital Partners, London, UK, predicts that larger pharmaceutical companies may have similar interests. Certain companies will struggle more than others with accruing investment from venture capital firms.

Pharmaceutical 69

Pharmaceutical Manufacturing Government Medicine 69

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Pharmaceutical Marketing 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Manufacturing 52

Manufacturing Pharmaceutical Pharmaceutical manufacturing Safety 52